METTL Family in Healthy and Disease
Jiejie He,
No information about this author
Fengchen Hao,
No information about this author
Shiqi Song
No information about this author
et al.
Molecular Biomedicine,
Journal Year:
2024,
Volume and Issue:
5(1)
Published: Aug. 19, 2024
Abstract
Transcription,
RNA
splicing,
translation,
and
post-translational
protein
modification
are
fundamental
processes
of
gene
expression.
Epigenetic
modifications,
such
as
DNA
methylation,
play
a
crucial
role
in
regulating
The
methyltransferase-like
(METTL)
family,
constituent
the
7-β-strand
(7BS)
methyltransferase
subfamily,
is
broadly
distributed
across
cell
nucleus,
cytoplasm,
mitochondria.
Members
METTL
through
their
S-adenosyl
methionine
(SAM)
binding
domain,
can
transfer
methyl
groups
to
DNA,
RNA,
or
proteins,
thereby
impacting
replication,
transcription,
mRNA
participate
maintenance
normal
function
promote
disease
development.
This
review
primarily
examines
involvement
family
differentiation,
mitochondrial
function,
its
association
with
tumor
formation,
nervous
system,
cardiovascular
diseases.
Notably,
intricately
linked
cellular
particularly
regulation
translation
factors.
represent
important
molecules
development
associated
patient
immunity
tolerance
radiotherapy
chemotherapy.
Moreover,
future
research
directions
could
include
drugs
antibodies
targeting
structural
domains,
utilizing
nanomaterials
carry
miRNA
corresponding
mRNA.
Additionally,
precise
mechanisms
underlying
interactions
between
factors
remain
be
clarified.
Language: Английский
RNA m6A Methylation and Alzheimer's Disease: Current Evidence and Future Perspectives
Wenqi Pan,
No information about this author
Yan Chen,
No information about this author
Yuesi Xu
No information about this author
et al.
Human Brain,
Journal Year:
2024,
Volume and Issue:
3(1)
Published: March 15, 2024
Background:
Alzheimer’s
disease
(AD)
is
the
most
common
neurodegenerative
characterized
by
pathological
accumulation
of
b-amyloid
and
neurofibrillary
tangles.
Despite
substantial
progress
in
both
basic
clinical
research
on
AD,
detailed
mechanism
AD
pathogenesis
still
elusive.
RNA
N6-methyladenosine
methylation
(m6A)
predominant
post-transcriptional
modification
eukaryotic
mRNA,
prominently
enriched
mammalian
brain.
Notably,
m6A-modified
showed
significant
changes
during
development
indicating
an
important
role
this
pathogenesis.
Aim:
In
study,
we
aim
to
provide
a
summary
recent
advances
highlighting
indispensable
m6A
Result:
From
perspective
modification,
review
our
current
understanding
association
between
machinery
risk
factors
as
well
its
involvement
various
pathophysiological
hallmarks
AD.
We
also
discuss
main
obstacles
studies
about
corresponding
caveats
solutions
them.
Conclusion:
This
emphasizes
significance
investigating
context
highlights
considerable
potential
for
emerge
novel
therapeutic
target
Language: Английский